Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and involucrin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with involucrin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(involucrin)		Trials
(involucrin)		Recent Studies (post-2010) (involucrin)
9,1561875529058183

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantagrel, F; Danker, K; Fischer, A; Kleuser, B; Laabs, S; Löwe, W; Mickeleit, M; Müller, D; Reutter, W; Zimmermann-Kordmann, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and involucrin

ArticleYear
The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cells.
    Chembiochem : a European journal of chemical biology, 2006, Volume: 7, Issue:3

    Topics: Cell Differentiation; Cell Line; Cell Proliferation; Chromatography, Thin Layer; Humans; Inositol; Magnetic Resonance Spectroscopy; Mass Spectrometry; Platelet Activating Factor; Protein Precursors; Transglutaminases

2006